Goldberg Itzhak's Form 4 filing
Elicio Therapeutics, Inc. (ELTX) · filed Nov 17, 2021
- Accession no.
- 0001601485-21-000075
- Filed
- Nov 17, 2021
- Trade date
- Jun 24-Nov 16, 2021
- Filing delay
- 146 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $629.0K. It was filed 146 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldberg ItzhakCIK 0001607858 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2021 | Common Stock | FTax withholdingDisposed | −47,410 | $13.78 | −$653,309.8 | 2,020,068 | Direct | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −111,505 | $4.17F3 | −$464,975.85 | 1,908,563 | Direct | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −38,495 | $4.26F4 | −$163,988.7 | 1,870,068 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.48 inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.38 inclusive.
Referenced by the price of 1 transaction in Table I.
Remarks
Executive Chairman and Chief Scientific Officer